"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
(Generic versions may still be available.)
DOSAGE AND ADMINISTRATION
Best results are obtained if the tablets are administered at the first sign of an attack.
The average adult dose is 2 tablets at the start of a vascular headache (migraine) attack; followed by 1 additional tablet every 1 / 2 hour if needed, up to 6 tablets per attack. Total weekly dosage should not exceed 10 tablets.
Wigraine (ergotamine and caffeine) ® tablets are white tablets embossed with "ORGANON 542" on one side. They are individually foil stripped and packaged in boxes of 20's NDC #0052-0542-20 and 100's NDC #0052-0542-91.
Wigraine (ergotamine and caffeine) ® tablets should be stored at a maximum of 30°C (86°F).
West Orange, NJ 07052
Last reviewed on RxList: 12/8/2004
Additional Wigraine Information
Wigraine - User Reviews
Wigraine User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find the secrets to longer life.